Health Sciences Acquisitions Corporation 2
NASDAQ: HSAQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Roderick Tze Ian Wong
- Headquarters
- New York City, United States
- IPO year
- 2020
- Market cap
- $149.2M
Loading HSAQ…
Loading profile data…Frequently asked questions about HSAQ
What does Health Sciences Acquisitions Corporation 2 (HSAQ) do?
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North Americ...
Where does HSAQ trade?
Health Sciences Acquisitions Corporation 2 (HSAQ) trades on the NASDAQ Capital Market.
What sector is HSAQ in?
Health Sciences Acquisitions Corporation 2 (HSAQ) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Health Sciences Acquisitions Corporation 2?
Roderick Tze Ian Wong is the chief executive officer of Health Sciences Acquisitions Corporation 2 (HSAQ).
Where is Health Sciences Acquisitions Corporation 2 headquartered?
Health Sciences Acquisitions Corporation 2 is headquartered in United States.
Does HSAQ pay a dividend?
Health Sciences Acquisitions Corporation 2 (HSAQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HSAQ go public?
Health Sciences Acquisitions Corporation 2 (HSAQ) completed its initial public offering in 2020.